Of importance, emerging evidence have shown that YAP is overexpressed and contributes to acquired resistance and poor prognosis of cetuximab in HNSCC or EGFR TKIs in lung cancers52–56. Here, EGFR is linked to head and neck squamous cell carcinoma.